None
Quote | Emerald Bioscience Inc (OTCMKTS:EMBI)
Last: | $0.09 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0925 |
Close: | $0.09 |
High: | $0.1 |
Low: | $0.088 |
Volume: | 6,962,748 |
Last Trade Date Time: | 01/18/2021 04:54:29 pm |
News | Emerald Bioscience Inc (OTCMKTS:EMBI)
San Diego, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with s...
San Diego, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with s...
Message Board Posts | Emerald Bioscience Inc (OTCMKTS:EMBI)
Subject | By | Source | When |
---|---|---|---|
Is this too late to buy this stock? | HoanTuong | investorshub | 01/15/2021 4:15:08 PM |
This stock you can go long | Dutchpaul1 | investorshub | 01/14/2021 12:46:57 PM |
Grabbed a starter on $EMBI this morning. | PepsiMan | investorshub | 01/13/2021 5:26:11 PM |
$EMBI - Emerald Bioscience Inc Forecast - CNNMoney.com | Dutchpaul1 | investorshub | 01/13/2021 12:29:53 PM |
Yahoo Finance...look $EMBI | Dutchpaul1 | investorshub | 01/08/2021 10:56:28 PM |
News, Short Squeeze, Breakout and More Instantly...
Emerald Bioscience Inc Company Name:
EMBI Stock Symbol:
OTCMKTS Market:
San Diego, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with s...
San Diego, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with s...
San Diego, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with si...